Advantages and limitations of antihypertensive treatment for stroke risk in a general population: The Akita Stroke Registry

Acta Cardiologica

Volumn 66, Issue 6, 2011, Pages 729-735

  Izumi, Manabu ^a   Suzuki, Kazuo ^b   Sakamoto, Tetsuya ^c   Hayashi, Masato ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^c Akita Kumiai General Hospital   (Japan)

^d Hiraka General Hospital   (Japan)

Author keywords

Blood pressure; Risk factors; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL EXAMINATION; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RISK FACTOR; STROKE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 83755173168     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.6.2136956     Document Type: Article

References (26)

1. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 1024.
2. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-15.
3. Tumbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospective-designed overviews of randomized trials. Lancet 2003; 362: 1527-35.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
5. Kang G, Guo L, Guo Z, Hu X, Wu M, Zhou Z, Zhou H, Liu S, Chen F. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease. Circ J 2010; 74: 456-61.
6. Igase M, Tabara Y, Igase K, Nagai T, Ochi N, Kido T, Nakura J, Sadamoto K, Kohara K, Miki T. Asymptomatic cerebral microbleeds seen in healthy subjects have a strong association with asymptomatic lacunar infarction. Circ J 2009; 73: 530-3.
7. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow-up study after two decades. Br Med J 1998; 317: 167-71.
8. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK. Stroke and coronary heart disease in treated hypertension: a prospective cohort study over three decades. J Intern Med 2005; 257: 496-502.
9. Benetos A, Thomas F, Bean KE, Guize L. Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens 2003; 21: 1635-40.
10. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC. Risk profiles and prognosis of treated and untreated hypertensive men and woman in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens 2004; 18: 615-22.
11. Li C, Engstrom G, Hedblad B, Berglund G, Janzon L Blood pressure control and risk of stroke: a population-based prospective cohort study. Stroke 2005; 369: 725-30.
12. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
13. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
14. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S; Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707-16.
15. Asayama K, Ohkubo T, Yoshida S, Suzuki K, Metoki H, Harada A, Murakami Y, Ohashi Y, Ueshima H, Imai Y; Japan Arteriosclerosis Longitudinal Study (JALS) group. Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study. J Hypertens 2009; 27: 357-64.
16. Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, Kajii E, Pickering TG, Kario K; Jichi Medical School Cohort Investigators Group. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res 2008; 31: 1323-30.
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
18. Nakaji S, Parodi S, Fontana V, Umeda T, Suzuki K, Sakamoto J, Fukuda S, Wada S, Sugawara K. Seasonal changes in mortality rates from main causes of death in Japan (1970-1999). Eur J Epidemiol 2004; 19: 905-13.
19. Aylin P, Morris S, Wakefield J, Grossinho A, Jarup L, Elliott P. Temperature, housing, deprivation and their relationship to excess winter mortality in Great Britain, 1986-1996. Int J Epidemiol 2001; 30: 1100-8.
20. Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 1999; 34: 1181-5.
21. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005; 23: 1217-23.
22. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315-20.
23. Irie K, Yamaguchi T, Minematsu K, Omae T. The J-curve phenomenon in stroke recurrence. Stroke 1993; 24: 1844-9.
24. Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, MacMahon S, Chalmers J; PROGRESS Collaborative Group. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke 2006; 37: 1497-502.
25. Zanchetti A. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens 2009; 27: 1509-20.
26. Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K, Okayama A, Kawano Y. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension 2008; 52: 652-9.